HemaClinix

HemaClinix, an innovative start-up with a compelling mission to enhance healthcare accessibility, is dedicated to developing cutting-edge point-of-care devices. Our primary focus is on addressing the pressing healthcare needs in Canada and beyond. At the forefront of our product portfolio is a revolutionary microfluidic-based chip designed for the rapid and accurate assessment of Prothrombin Time (PT)/INR tests. The significance of our mission lies in the transformative potential of our proprietary technology. By streamlining PT/INR testing, our device offers a game-changing solution for both emergency departments and homebound patients undergoing anticoagulant therapy. This microfluidic chip delivers results in less than 15 minutes, utilizing just a minimal blood sample, thereby revolutionizing accessibility, affordability, and accuracy in PT/INR testing.